Vertebral body collapse after spine stereotactic body radiation therapy: a single-center institutional experience

Radiol Oncol. 2024 Jun 12;58(3):425-431. doi: 10.2478/raon-2024-0033. eCollection 2024 Sep 1.

Abstract

Background: Spine stereotactic body radiation therapy (SBRT) for the treatment of metastatic disease is increasingly utilized owing to improved pain and local control over conventional regimens. Vertebral body collapse (VBC) is an important toxicity following spine SBRT. We investigated our institutional experience with spine SBRT as it relates to VBC and spinal instability neoplastic score (SINS).

Patients and methods: Records of 83 patients with 100 spinal lesions treated with SBRT between 2007 and 2022 were reviewed. Clinical information was abstracted from the medical record. The primary endpoint was post-treatment VBC. Logistic univariate analysis was performed to identify clinical factors associated with VBC.

Results: Median dose and number of fractions used was 24 Gy and 3 fractions, respectively. There were 10 spine segments that developed VBC (10%) after spine SBRT. Median time to VBC was 2.4 months. Of the 11 spine segments that underwent kyphoplasty prior to SBRT, none developed subsequent VBC. No factors were associated with VBC on univariate analysis.

Conclusions: The rate of vertebral body collapse following spine SBRT is low. Prophylactic kyphoplasty may provide protection against VBC and should be considered for patients at high risk for fracture.

Keywords: kyphoplasty; spinal instability; spine metastasis; stereotactic body radiation therapy; vertebral compression fracture.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Kyphoplasty / adverse effects
  • Kyphoplasty / methods
  • Male
  • Middle Aged
  • Radiosurgery* / adverse effects
  • Radiosurgery* / methods
  • Retrospective Studies
  • Spinal Fractures / etiology
  • Spinal Neoplasms* / radiotherapy
  • Spinal Neoplasms* / secondary
  • Spinal Neoplasms* / surgery
  • Vertebral Body